Deadly Super Bugs Lurking Amongst Us: a Futile Effort or Is There a Cure



    HALIFAX, Nova Scotia, March 23 /CNW/ - Since OPERATION Iraqi Freedom
began in 2003; more than 700 US, British and Canadian soldiers have been
infected or colonized with Acinetobacter baumannii. A significant number of
additional cases have been found among wounded Iraqi civilians. The Armed
Forces Institute of Pathology has recorded seven deaths caused by the bacteria
in US hospitals along the evacuation chain. Four were unlucky civilians who
picked up the bug at Walter Reed Army Medical Center in Washington, DC, while
undergoing treatment for other life-threatening conditions. Another was a 63-
year-old woman, also chronically ill, who shared a ward at Landstuhl Germany
with infected coalition troops.
    Acinetobacter is only one of many bacterial nemeses prowling around in
ICUs and neonatal units in hospitals all over the world. Cases are often under
reported and it is well known that resistant bacterial infections kill
thousands of ordinary people every year across Canada.
    Forerunners of the bug causing the military infections have been making
deadly incursions into civilian hospitals for more than a decade. In the early
1990s, 1,400 people were infected or colonized at a single facility in Spain.
A few years later, particularly virulent strains of the bacteria spread
through three Israeli hospitals, killing half of the infected patients. Death
by Acinetobacter can take many forms: catastrophic fevers, pneumonia,
meningitis, infections of the spine, and sepsis of the blood. Patients who
survive face longer hospital stays, more surgery, and severe complications.
    You may not be surprised to learn that this nasty infectious organism is
easily killed by stabilised Allicin extracts such as Allimax(R) and this work
has now been presented at The Canadian Association for Clinical Microbiology
and Infectious Diseases meeting in Halifax Novo Scotia in March 2007. This is
shown below as a summary.
    The antimicrobial activity of a novel aqueous allicin extract (AB1000 -
Allimax Gouttes and Spray) was tested against 11 clinical isolates of DRAB.
The allicin content of these extracts was confirmed using HPLC. Strains were
screened for activity using agar diffusion methods, MIC's and MBC's were
carried out and growth (using spectroscopy at 490nm) and killing curves (using
viable counts) for selected organisms were determined.
    Presented at the Canadian Association for Clinical Microbiology and
Infectious Diseases meeting in Halifax Novo Scotia in March 2007

    
    More information available from:
    Kate Maguire CLM Health
    416-263-0004
    kate@clmhealth.com
    




For further information:

For further information: Kate Maguire of CLM Health, +1-416-263-0004,
kate@clmhealth.com

Organization Profile

ALLICIN CANADA

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890